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Herpesvirus saimiri can be used as an efficient gene expression vector for human T lymphocytes and thus may allow
applications in experimental leukemia therapy. We constructed recombinant viruses for the functional expression of the
thymidine kinase (TK) of herpes simplex virus type 1 (HSV) as a suicide gene. These viruses reliably allowed the targeted
elimination of transduced nonpermissive human T cells in vitro after the administration of ganciclovir. To test the reliability
of this function under the most stringent permissive conditions, in this study we analyzed the influence of the prodrugs
ganciclovir and acyclovir in common marmosets on the acute leukemogenesis induced by either wild-type herpesvirus
saimiri C488 or by a recombinant derivative expressing TK of HSV. Antiviral drug treatment did not influence the rapid
development of acute disease. In contrast, the presence of the HSV tk gene resulted in a faster disease progression. In
addition, HSV TK-expressing viruses showed faster replication than wild-type virus in culture at low serum concentrations.
Thus, HSV TK accelerates the replication of herpesvirus saimiri and enhances its pathogenicity. This should be generally
considered when HSV TK is applied as a transgene in replication-competent DNA virus vectors for gene therapy. © 2000
Academic PressKey Words: aciclovir; Callithrix jacchus; common marmosets; ganciclovir; herpes simplex virus; herpesvirus saimiri;
pathogenicity; suicide gene; T-cell leukemia; thymidine kinase.
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iINTRODUCTION
Herpesvirus saimiri (Saimiriine herpesvirus type 2) is a
g2-herpesvirus (rhadinovirus) of South American squirrel
onkeys (Saimiri sciureus) in which the virus persists
ithout causing disease. However, in other New World
onkey species such as cottontop tamarins (Saguinus
edipus) and in common marmosets (Callithrix jacchus),
erpesvirus saimiri induces acute T-cell lymphomas
eading to death within a few weeks after infection. The
ymphoma is associated with massive virus replication
nd viral gene expression. The virus can be easily re-
overed by cocultivation of peripheral blood mononu-
lear cells (PBMCs) with permissive epithelial owl mon-
ey kidney (OMK) cells (Daniel et al., 1976b; Duboise et
l., 1998a; Knappe et al., 1998a,b).
After infection of human PBMC cultures with herpes-
irus saimiri C488, the T lymphocytes are transformed to
table proliferation (Biesinger et al., 1992). Although
growth transformed, the cells retain many essential func-
tions of their nontransformed parental cells, including
their MHC-restricted antigen specificity (Bro¨ker et al.,
1993; De Carli et al., 1993; Mittru¨cker et al., 1993; Weber
et al., 1993). Stimulation induces cytotoxicity and the1 To whom reprint requests should be addressed. Fax: 49-9131-85-
6493. E-mail: fickenscher@viro.med.uni-erlangen.de.
445production of cytokines such as interferon-g or tumor
necrosis factor-a (TNF-a). Either CD41 or CD81 cells and
ither ab- or gd-T cells can be transformed (Biesinger et
l., 1992; Fickenscher et al., 1997; Klein et al., 1996;
acheco-Castro et al., 1996; Yasukawa et al., 1995). In the
rowth-transformed human T lymphocytes that do not
roduce virion particles, only a few viral genes are ex-
ressed (Fickenscher et al., 1996; Knappe et al., 1997).
ne of them is the oncogene stpC, whose gene product
nteracts with cellular Ras and TNF-a receptor-associ-
ated factors, transforms rodent fibroblasts, and causes
tumors in transgenic mice (Jung and Desrosiers, 1995;
Jung et al., 1991; Lee et al., 1999; Murphy et al., 1994).
Another one, Tip, is translated from the same bicistronic
transcript and interacts specifically with the T-cellular
tyrosine kinase Lck (Biesinger et al., 1995). Both stpC and
tip are necessary for T-cell transformation (Duboise et
al., 1998a; Knappe et al., 1997).
Gene transfer into human T cells and long-term ex-
pression of transgenes in these cells remains difficult by
using classic methods, including retroviral vectors. Her-
pesvirus saimiri has three major features that are prom-
ising for vector development for human T cells. First, the
virus does not integrate into the cellular chromosomes.
The virus genome persists episomally in the nonpermis-
sive human T cells in a high and stable copy number that
precludes problems arising from chromosomal integra-
0042-6822/00 $35.00
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446 HILLER ET AL.tion such as insertional mutagenesis and silencing on
chromatin inactivation (Biesinger et al., 1992; Ficken-
scher et al., 1996, 1997). Second, as mentioned, the virus
strain C488 is able to transform human T cells to stable
growth in culture, which facilitates the amplification of
functional T cells (Biesinger et al., 1992). These growth-
transformed T cells appear to be nontumorigenic; if large
cell numbers of autologous transformed T lymphocytes
had been reinfused into the donor macaques, the cells
were well tolerated and persisted over several months
without side effects and without the occurrence of lym-
phoma or leukemia (Knappe et al., 2000). Third, the virus
genome can be used for the functional long-term expres-
sion of foreign genes in human T cells (Hiller et al., 2000).
lthough virion production has never been observed for
erpesvirus saimiri-transformed human T cells, possible
herapeutic applications should include additional safety
echanisms such as an active elimination function me-
iated by a suicide gene. Moreover, packaging cell-
ependent and replication-deficient vector variants
ould be required to preclude any virus replication in
ivo.
Vectors based on herpesvirus saimiri C488 might al-
ow novel developments in T-cell-mediated immunother-
py. One possible application of such T-cell vectors
ould be for the leukemia therapy mediated by alloge-
eic T cells. Persisting or relapsing residual leukemic
isease and other hematological disorders can be
reated efficiently by adoptive immunotherapy with allo-
eneic T cells after stem-cell transplantation (Collins et
l., 1997; Kolb and Holler, 1997; Kolb et al., 1990, 1995;
Slavin et al., 1988, 1995, 1996). Although the T-cell-medi-
ated graft-versus-leukemia effect is highly active against
tumor cells, the allogeneic T-cell therapy is hampered by
the frequent side effect of graft-versus-host disease,
which can hardly be controlled by conventional therapy.
In the case of such complications, suicide gene expres-
sion has been applied for the targeted elimination of the
grafted cells. The herpes simplex virus type 1 (HSV) gene
thymidine kinase (tk) is the prototype suicide gene that
has been widely used in experimental oncology. TK ac-
tivates ganciclovir (GCV) to a toxic metabolite inducing
cell death. By the use of retroviral vectors, the tk gene
was transduced into the donor T cells before transplan-
tation (Bonini et al., 1997; Bordignon et al., 1995; Contas-
ot et al., 1998; Munshi et al., 1997; Tiberghien et al.,
994, 1997). In three patients with graft-versus-host dis-
ase, the administration of GCV eliminated the grafted T
ells and stopped the acute clinical complications (Ver-
eletti et al., 1998).
Our aim was to adapt herpesvirus saimiri for a possi-
le application in allogeneic T-cell therapy. For this pur-
ose, the prodrug-activating tk gene of HSV was inserted
nto the genome of herpesvirus saimiri by homologous
ecombination. A series of recombinant viruses effi-
iently expressed the transgene during lytic infection ofermissive epithelial cells and during persistent infec-
ion of nonpermissive human T cells. In contrast to wild-
ype virus, the replication of the tk mutant herpesvirus
aimiri was sensitive to GCV or acyclovir (ACV) treatment
n culture (Hiller et al., 2000). After infection with wild-
ype or recombinant viruses, human T cells were trans-
ormed to stable growth. Nonpermissive, TK-expressing
ransformed T cells were efficiently eliminated in the
resence of low concentrations of GCV. This elimination
echanism remained fully functional over an observa-
ion period of 1 year (Hiller et al., 2000). At any time
uring the course of a therapeutic application, such
k-transduced nonpermissive human T cells might be
liminated after the administration of GCV to remove the
ransfused allogeneic cells in the case of unwanted side
ffects such as acute graft-versus-host disease.
To study the degree of the functional reliability of this
uicide gene system, we chose one of the most stringent
ystems available, namely leukemia induction by her-
esvirus saimiri in susceptible New World primates. In
his report, we analyzed the previously characterized
utant TK-2 in comparison to the wild-type virus C488 in
ommon marmosets for its susceptibility to antiviral che-
otherapy and for its pathogenicity. Our unexpected
esults indicate that antiviral drugs do not act rapidly
nough to interfere with the massive virus replication
uring acute viral leukemogenesis. In addition, the tk
ransgene accelerated virus replication and disease pro-
ression.
RESULTS
esign of the infection and chemotherapy experiment
In comparison to the wild-type herpesvirus saimiri
488, the previously characterized HSV TK-expressing
utant virus TK-2 (Hiller et al., 2000) was tested in com-
on marmosets (Callithrix jacchus) for its pathogenic
roperties and for its susceptibility to antiviral chemo-
herapy by ACV and GCV. Ten healthy animals were
ntravenously infected either with C488 or with TK-2 at a
issue culture infectious dose (TCID)50 of 10
6 in 1 ml
ell-free tissue culture supernatant. The high inoculum
ose was applied to exclude limiting infection condi-
ions. Drug therapy was performed at two different reg-
mens: either early (days 23 to 114) or late (days 17 to
121) after infection. To ensure reliable drug concentra-
tions, the drugs were subcutaneously injected in phos-
phate-buffered saline: ACV at a dosage of 30 mg/kg/d
and GCV at a dosage of 15 mg/kg/d. This dosage is
frequently used for other experimental and clinical appli-
cations. The individual treatment groups consisted of
two animals each (Table 1).
Disease progression after infectionAll infected animals developed signs of disease al-
most independently of the respective form of drug treat-
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448 HILLER ET AL.ment. The onset of disease was rapid, leading to apathy
and pronounced diarrhea within a few hours. Necropsy
was performed a few hours after the onset of symptoms.
Although relevant drug-related differences were not en-
FIG. 1. Survival curve of infected animals. Common marmosets were
virus TK-2. Animals infected with TK-2 developed acute disease almos
disease was delayed after wild-type virus infection. The animal numbe
FIG. 2. Histopathological findings. The tissue sections were fixed in
3763 magnification. (A) Periportal infiltration of lymphoblasts in the live
Granulomatous infiltration of lymphoblasts in the liver. Several mitotic f
granulocytes (liver, animal 8532). (C) Severe granulomatous enteritis w
8532). (D) Infiltrate composed of blast-like lymphocytes and granulocytes ben
infiltration (ductus epididymidis, animal 8564).countered, the mutant virus TK-2 induced a more rapid
disease progression (Fig. 1).
On necropsy and subsequent histological examina-
tion, all animals showed similar signs of peripheral T-cell
nously infected with 106 TCID50 of either wild-type virus C488 or mutant
ronously at 15–16 days postinfection (dpi). In comparison, the onset of
indicated in the survival curve.
n and stained with hematoxylin/eosin. The photographs were taken at
filtrate is mixed with eosinophilic granulocytes (liver, animal 8532). (B)
are marked with arrows. Again, the infiltrate is mixed with eosinophilic
ed infiltrate and massive crypt abscess formation (duodenum, animalintraveFormali
r. The in
igures
ith mixeath the epithelium demonstrating the epitheliotropic character of the
ird row
nd wer
449HERPESVIRUS SAIMIRI PATHOGENICITY ENHANCED BY HSV-1 TKlymphoma (Figs. 2A–2D). These consisted of marked
lymphoproliferative alterations, primarily in the form of
perivascular and interstitial lymphoid cell infiltrations
with pleomorphic, blast- and mitosis-rich cell infiltrates,
which also contained granulocytic, mainly eosinophilic
cells (Figs. 2A and 2B). The lymphoid cell proliferations
consisted of medium-sized to large blasts with vesicular
nuclei and prominent nucleoli. Within the lymphoid cell
proliferations, numerous mitoses with occasional atypi-
cal patterns were present (Fig. 2B). Such cell infiltrates
were found in various stages in nearly all organs of all
animals. The infiltrates were most pronounced in the
liver, kidney, and spleen. Additional severe infiltrations
were detectable in all organs with epithelial components,
including bile ducts and gallbladder, pancreatic ducts,
epididymis ducts (Fig. 2D), saliva ducts, and areas of
trachea and bronchi, and they resulted in severe inflam-
matory alterations. The lung parenchyme itself was less
affected.
Characteristic alterations of the lymphatic system
were apparent in differing severity in all animals. Lymph
nodes tended to be enlarged and showed an expansion
of sinal areas and enlargement of T-cell zones in para-
cortical areas, which can be attributed to the lymphopro-
liferative blast-like cell infiltrates described above. Cor-
responding lymphoproliferative cell infiltrates were also
FIG. 3. Demonstration of virus DNA from PBMC and ex vivo T-cell lin
was demonstrated by orf75-specific PCR resulting in a band of 360
tk-specific PCR yielding a 260-bp band (panels on the right). The individ
for infection (either C488 or TK-2). Negative controls with uninfected T
controls with transformed tamarin T-cell lines (B133 C488 and B133 TK
7 postinfection (pi), the second row from PBMC at day 14 pi, and the th
of virus DNA in T-cell lines that were isolated from thymus samples apresent in the gastrointestinal tract, primarily in the sub-
mucosal areas and radiating from there (Fig. 2C). Allanimals showed a gradual decrease in gastrointestinal
alterations from proximal to distal, with cecum and colon
generally showing the least alterations. The central ner-
vous system also showed alterations caused by infil-
trates, although they were less pronounced. In conclu-
sion, all animals showed diffuse systemic lymphoprolif-
erative organ infiltration.
The alterations were classified as low, medium, and
severe, according to the severity of the histological
changes. Obvious large tumors were not observed, al-
though nodular, tumor-like cell aggregates were begin-
ning to form in individual animals (Table 1). The morpho-
logical changes in the TK-2-infected animals were of
intermediate severity and were not influenced by drug
therapy. In contrast, the extent of histological anomalies
was generally reduced by any form of drug treatment in
the wild-type virus-infected animals. However, in many
wild-type virus-infected animals (7 of 10), a formation of
tumor nodules was encountered. This was hardly found
in mutant virus-infected monkeys (1 of 10).
Monitoring of infection and leukemogenesis
Blood samples were taken before infection, at weekly
intervals (days 17 and 114), and on necropsy. The blood
samples were tested for virus load by cocultivation of
A of both wild-type C488 and mutant TK-2 herpesvirus saimiri strains
t panels). The TK expression vector virus DNA was detected with a
ples are labeled with the animal number and the respective virus used
nd with water instead of DNA were run in parallel, as well as positive
er et al., 2000). The upper panels show the results from PBMC at day
from PBMC at necropsy. The lower panels demonstrate the presence
e grown without interleukin-2 for .2 months.es. DN
bp (lef
ual sam
cells a
-2; Hillpermissive OMK cells with 3, 10, 30, and 100 ml whole
blood (Table 1). Blood samples drawn after 1 week from
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450 HILLER ET AL.mutant virus-infected animals (4 of 10) already released
virus, whereas this was not the case at day 7 after
wild-type virus infection. Two weeks after infection, all
mutant virus-infected marmosets had high virus load,
whereas only 5 of 10 wild-type virus-infected animals
released measurable amounts of virus from their blood
cells. At the late stage of disease (day 14), 3 ml blood was
ufficient for virus isolation in all mutant virus-infected
onkeys, but only in 3 of 10 wild-type virus-infected
nimals.
Primary cells were purified from blood and various
rgans (thymus, spleen, and lymph nodes). Samples of
hese fresh cell preparations were used for the direct
emonstration of virus DNA by PCR. Both the mutant and
he wild-type virus DNAs were detected with a PCR for
he viral structural gene orf75 (primers HF596 and
HF597). The mutant virus DNA was specifically demon-
strated with a PCR for the HSV tk gene (primers HF344
and HF370). Further samples of freshly isolated cells
were cocultivated with permissive OMK cells to reisolate
the virus. Other samples were cultivated in complete
T-cell medium without interleukin-2 to isolate lymphoma
T
GCV-Sensitivity of Limiting Dilution Titers [pfu/m
Animal Virus
Drug
treatment
Therapy
period
8596 C488 None None
8532 C488 None None
8809 TK-2 None None
8533 TK-2 None None
8817 TK-2 GCV Early
8767 TK-2 GCV Early
8720 TK-2 GCV Late
8742 TK-2 GCV Late
Titers in pfu/ml.
FIG. 4. Replication of wild-type and recombinant viruses. Permissive
OMK cells were infected with equal titers (TCID50 5 10
6/ml) of either
ild-type C488 or tk-mutant TK-2 virus in presence of either 2% or 10%
BS. Every second day, samples of the supernatants were titrated on
ubconfluent OMK layers in microtiter plates. Early after infection, ther
s
utant virus had an obvious replication advantage, which was even
ore pronounced under low FBS concentrations.cell lines. In each individual case, the virus reisolation
and the generation of tumor cell lines were successful
from tissue or blood samples taken during necropsy.
In almost all mutant virus-infected animals, virus DNA
was detectable in PBMCs from day 7 postinfection (Table
1, Fig. 3). In contrast, virus DNA was detectable in
PBMCs from wild-type virus-infected animals at day 14
for the first time. Virus DNA was demonstrated in PBMC
samples of all terminally sick animals. Stably proliferat-
ing T-cell lines were isolated from late PBMC and nec-
ropsy tissue samples (thymus, spleen, and lymph nodes).
The resulting T-cell lines were genotypically confirmed
by orf75- and tk-specific PCR (Fig. 3, lower panels). The
respective virus strain, wild type or mutant, was reiso-
lated by cocultivating fresh cells from PBMCs or organs
from necropsy samples in each individual case. The
genotype of these viruses was confirmed by PCR and
Southern blot hybridization of PCR products.
Reisolated viruses at TCID50 of .10
6/ml were tested
or drug sensitivity by end point titration in the presence
f increasing concentrations of GCV. Although wild-type
irus C488 did not react significantly, there was a strong
eduction in virus titers of the reisolated TK-2 virus in
resence of GCV (Table 2). Thus the TK-2 virus did not
scape the drug treatment by inactivation of the tk gene.
nhanced replication of the TK-2 mutant virus in vitro
To confirm these observations in vitro, the replication
f the wild-type C488 virus and the TK expression mutant
as compared in OMK cells in presence of either 2% or
0% FBS (Fig. 4). Subconfluent cells (175 cm2, 50-ml
volume) were infected with equal titers of either virus
(250 ml of 106 TCID50/ml). Every other day, 1-ml samples
ere taken from the supernatants of the infected cul-
ures. These samples were serially diluted and tested for
heir limiting dilution titer each in six parallel cultures in
8-well plates. During the first 6 days, the mutant virus
ruses Reisolated from Nexropsy Blood Samples
GCV (mM)
0 50 250 500 1000
106 .106 .106 .106 106
106 .106 .106 .106 106
106 .106 106 104 101
106 .106 105 105 103
106 .106 .106 104 101
106 .106 105 104 102
106 .106 105 104 103
106 .106 105 104 102ABLE 2
l] of Vi
.
.
.
.
.
.
.
.eplicated faster than the wild-type virus under reduced
erum concentrations (2% FBS), resulting in a titer differ-
451HERPESVIRUS SAIMIRI PATHOGENICITY ENHANCED BY HSV-1 TKence of up to 100- fold. Under conventional 10% FBS
concentration, the replication advantage was detectable
for 4 days only (Fig. 4). Finally, all of the parallel cultures
yielded a titer of 106/ml.
DISCUSSION
In common marmosets (Callithrix jacchus), the TK-
expressing mutant virus TK-2 (Hiller et al., 2000) was
tested in comparison to the wild-type herpesvirus saimiri
C488 for pathogenicity and for sensitivity to antiviral
chemotherapy. Despite antiviral treatment with ACV or
GCV, all animals developed acute disease after infection
and were finally subjected to necropsy (Fig. 1). The lack
of drug effects was not due to escape mutation of the tk
gene, because the reisolated viruses remained strongly
susceptible to GCV treatment in vitro (Table 2). Histolog-
ically, all animals showed signs of acute peripheral T-cell
lymphomas (Fig. 2). When we were planning the exper-
iment, we expected TK expression to allow control of the
mutant virus-induced lymphomas by activation of GCV to
the toxic derivative. The unusually rapid progression of
herpesvirus saimiri-induced T-cell lymphoma-like lesions
in common marmosets seems to be the reason for the
unexpected outcome. In contrast to the rapid lymphoma
development, the therapeutic effects of GCV require at
least 1 week of treatment in most in vitro and in vivo
studies (Bush et al., 1998; Cohen et al., 1997; Munshi et
al., 1997). In this context, it is conceivable that the spread
of infection is much more rapid in this system than the
slow onset of antiviral activity of GCV in the individual
cell. Only in the wild-type virus-infected animals 8632
and 8736 does it remain possible that GCV at the early
time regimen had some limiting effect in postponing the
onset of disease. On histological analysis, the severity of
disease was reduced by drug treatment of the wild-type
virus-infected animals (Table 1). This difference was not
observed with the mutant virus.
Surprisingly, all of the TK-2 mutant virus-infected ani-
mals showed an accelerated disease progression (Fig.
1). The results of virus isolations, tumor cell cultivations,
and DNA tests indicated that the mutant virus had a
replication advantage, at least during the early phase of
infection. In comparison to the wild-type virus, the TK-2
mutant virus DNA was detectable significantly earlier
after infection in PBMCs. In addition, tumor cell lines
could be grown from day-7 PBMC samples in the case of
the mutant virus only (Table 1). Thus the suicide gene
obviously provided an advantage for the mutant virus
replication in the early phase of infection. Early studies
had already shown that the tk gene was required for HSV
replication under reduced serum concentrations, while it
was dispensable under high serum concentrations in
actively dividing cells (Jamieson et al., 1974). The infec-
tion of mice with tk deletion mutants of HSV leads to
latent, nonpermissive infection of nondividing cells suchas neurons. A reactivation of the mutant virus from latent
infection was achieved only if the deletion had been
repaired (Efstathiou et al., 1989). This indicates that TK
activity is a relevant factor for replication and secondarily
for pathogenicity if there are suboptimal replication con-
ditions such as low concentration of growth factors,
reduced mitosis rate, or poor nucleotide availability.
In tissue culture, the TK-2 virus mutant had been
shown to be much more sensitive to ACV or GCV treat-
ment in comparison to wild-type virus when tested for
limiting dilution titers. In this case, GCV induced up to
1000-fold repression of virus replication (Hiller et al.,
2000). Similar inhibition factors were observed in the
presence of GCV with recombinant viruses reisolated
from TK-2-infected animals (Table 2). In the early phase
of infection, however, the tk-expressing mutant repli-
cated in cell culture more rapidly compared with wild-
type virus (Fig. 4). Under low serum concentrations, the
titer difference was even more pronounced. In the late
phase of replication, both strains reached similar titers.
The availability of nucleotides is a limiting factor for DNA
synthesis. TK is a key enzyme in the pyrimidine salvage
pathway of nucleotide biosynthesis. Thus HSV TK ex-
pression leads to increased intracellular levels of TTP,
which facilitate viral DNA replication. The TK activity and
the susceptibility to antiviral drugs were transferred from
varicella zoster virus to HSV by the transfer of the tk gene
(Bevilacqua et al., 1995). In comparison to HSV TK, the
endogenous TK activity of herpesvirus saimiri and
closely related rhadinoviruses seems to be much weaker
and has been assigned to the genes orf21 and orf36
(Albrecht et al., 1992; Cannon et al., 1999; Cazaux et al.,
1998; Hiller et al., 2000). Thus the insertion of the HSV tk
gene into herpesvirus saimiri would result in an in-
creased TK activity in infected cells, which would explain
enhanced virus replication and, subsequently, enhanced
pathogenicity.
In our experiments with monkeys, a single TK-express-
ing mutant was compared with wild-type virus to keep
the animal number as small as possible. The enhanced
replication and pathogenesis were likely to be due to TK
expression. However, it cannot be formally excluded that
secondary effects unrelated to TK expression might
cause the different phenotype. This could be addressed
by testing additional tk virus mutants and revertants for
their pathogenic potential to formally prove that the phe-
notype is caused by the tk gene. Such additional exper-
iments would be standard and feasible if smaller, less-
developed animals such as mice could be used for this
purpose. However, in this case the additional virus mu-
tants would have to be tested for pathogenesis in pri-
mates. Such experiments have to meet high ethical stan-
dards, and the applications for primate experiments are
carefully reviewed for their expected scientific benefit.
We decided not to perform such additional tests, be-
cause the aim would be mainly confirmatory and the
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452 HILLER ET AL.scientific benefit would be questionable based on our
detailed characterization of the viruses in culture before
and after the animal experiment. We previously tested a
series of independent but similar tk mutants concerning
heir TK protein expression, their lytic replication, and
heir GCV sensitivity in simian and human T cells, with
imilar results for different independent mutants (Hiller et
l., 2000). Moreover, we have tested the replication of the
eisolated viruses for their sensitivity to GCV and ob-
erved that it was fully preserved in the mutant while
oor in the wild type (Table 2). Thus it is excluded that the
k mutant virus lost TK expression by escape mutation.
In our studies, we used the promoter of the house-
eeping gene phosphoglyceroyl kinase-1 (pgk-1) for
transgene expression (Hiller et al., 2000). This promoter
has been reliable in human T cells using either herpes-
virus saimiri or retrovirus vectors (Cooper et al., 2000;
Follenzi et al., 2000; Hiller et al., 2000). In another study,
he human cytomegalovirus (HCMV) immediate-early en-
ancer had been applied for driving transgene expres-
ion from a herpesvirus saimiri vector (Stevenson et al.,
000a). In that case, pluripotent murine embryonal stem
ells were transduced. During differentiation of these
ells, a differential transgene expression was encoun-
ered. These observations are in line with a previous
eries of reports on mosaic-like expression from the
CMV enhancer in transgenic animals (Baskar et al.,
996a,b; Furth et al., 1991; Koedood et al., 1995). In
ontrast, the pgk-1 promoter has also been used fre-
uently and reliably in transgenic applications with ubiq-
itous transgene expression. In human T cells trans-
uced with herpesvirus saimiri vectors, this promoter
as yielded strong and long-term transgene expression
Hiller et al., 2000, and unpublished data).
In contrast to the nonpermissive episomal persistence
f herpesvirus saimiri genomes in human T lymphocytes,
he leukemogenesis induced by herpesvirus saimiri in
eotropical monkeys is characterized by massive virus
eplication and strong viral gene expression. T cells from
nfected New World monkeys are semipermissive: they
re transformed and produce virus particles at the same
ime. Moreover, herpesvirus saimiri also replicates under
ystemic infection conditions in other cell types, presum-
bly in a broad spectrum of cells, including epithelia and
onnective tissue, and possibly also in endothelial cells.
eplication of herpesvirus saimiri in cell culture is well
nown for epithelial kidney cells such as Vero and OMK
Daniel et al., 1976b) and for the pancreatic carcinoma
ell line Panc-1 (Simmer et al., 1991; Stevenson et al.,
000b). A lung carcinoma cell line was also shown to
upport inducible virus production (Hall et al., 2000).
oreover, various primary culture conditions from ca-
ine lung or human fetal tissues have yielded infectious
irus (Daniel et al., 1976a; Melendez et al., 1975). Al-
hough only few virus genes such as stpC and tip are
xpressed in nonpermissive human T cells, a broad
t
lariety of virus genes is transcribed during lytic replica-
ion, including the endogenous tk gene of herpesvirus
aimiri (Fickenscher et al., 1996; Hiller et al., 2000). In
itro, wild-type and tk recombinant virus-infected neotro-
ical T-cell lines were highly sensitive to GCV, obviously
ue to the endogenous TK function of herpesvirus
aimiri. In contrast, wild-type virus replication was poorly
usceptible to GCV treatment in culture. This again sup-
orts our hypothesis that rapid virus replication is the
eason why the leukemogenesis in common marmosets
id not react to antiviral treatment. It is conceivable that
urther virus gene products with homology to cellular
roteins and with possible growth-stimulatory function
ould support leukemogenesis in the susceptible mon-
eys. However, deletion mutagenesis has shown that
ost of these accessory genes are not essential for
ransformation and leukemogenesis. This has been pub-
ished, for example, for the viral interleukin-17 and for the
iral superantigen homolog (Duboise et al., 1998b;
nappe et al., 1997, 1998a,b). However, it remains possi-
le that such accessory genes influence the phenotype
s described for the viral homolog to superantigens
Duboise et al., 1998b). Generally, most of the accessory
enes are presumed to play an important functional role
uring the apathogenic persistence in the natural host of
he virus, the squirrel monkey (Saimiri sciureus).
Although the results of this study were unexpected,
hey do not argue against herpesvirus saimiri as a vector
or human T cells for several reasons. First, herpesvirus
aimiri-transformed human T cells are not permissive
nd do not produce virus particles, as described in sev-
ral studies (Biesinger et al., 1992; Fickenscher et al.,
996, 1997; Knappe et al., 2000). Similarly, TK-2-trans-
uced human T cells were not permissive to the virus
Hiller et al., 2000). Second, the TK/GCV prodrug activa-
ion system is the prototype strategy. In the context of
erpesvirus vectors, alternative suicide genes should be
enerally considered, such as the enzyme cytochrome
450 2B1, which activates the cytostatic drug cyclophos-
hamide in the periphery (Chen et al., 1996). Third, it is a
eneral aim of vector development to preclude virus
eplication in vivo by generating packaging cell systems.
iral deletion variants for essential genes will only rep-
icate in trans-complementing packaging cell lines ex-
ressing the deleted function. On this basis, a pathoge-
etic role of TK expression would be excluded. However,
or all replication-competent DNA vector systems, possi-
ly even including adenovirus vectors, HSV tk as a trans-
ene should be carefully reconsidered.
MATERIALS AND METHODS
irus and T-cell cultures
Permissive OMK cells, primary lymphocytes, and
ransformed T cells were cultivated according to pub-
ished protocols (Fickenscher and Fleckenstein, 1998;
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453HERPESVIRUS SAIMIRI PATHOGENICITY ENHANCED BY HSV-1 TKHiller et al., 2000). OMK cells (CRL-1556; American Type
ulture Collection, Manassas, VA; Daniel et al., 1976b)
ere split once a week by a factor of 2, and the medium
as exchanged on day 4 (Dulbecco‘s modified Eagle’s
edium with 10% heat-inactivated FBS, 350 mg/ml glu-
tamine, and 100 mg/ml gentamicin). Virus titrations were
erformed by limiting dilution in microtiter plates (24- or
8-well plates). The titer was determined as the respec-
ive dilution step in which at least 50% of the infected
arallel cultures (four to six each) developed specific
ytopathic changes followed by complete lysis (TCID50).
onkey T cells were cultivated in absence of interleu-
in-2 in complete medium containing 45% RPMI 1640,
5% Panserin 401 (PAN, Aidenbach, Germany), 10% FBS,
50 mg/ml glutamine, and 100 mg/ml gentamicin. The
wild-type virus C488 (Biesinger et al., 1990; Desrosiers
and Falk, 1982) and the TK-expression mutant TK-2 (Hiller
et al., 2000) have been described before in detail. TK-2
carries the HSV tk reading frame under the control of
promoter and termination signals of the murine phospho-
glyceryl kinase gene. This expression cassette is in-
serted between orf75 and the terminal repetitions of
herpesvirus saimiri (Hiller et al., 2000).
Animals
Common marmosets (Callithrix jacchus) were pur-
ose-bred in the colony of the German Primate Center
Go¨ttingen, Germany). The experiment was performed
ased on permissions according to the national animal
rotection and gene technology safety regulations. To
imit the necessary number of animals, we compared the
reviously characterized virus mutant (TK-2) with wild-
ype virus under various drug treatment conditions. The
nfection conditions followed our protocol used before for
ottontop marmosets (Knappe et al., 1998a,b). The ani-
als were intravenously injected with either the wild-
ype or the mutant virus with 106 TCID50 in 1 ml. The
rugs GCV (Cymeven; Syntex, Grenzach-Wyhlen, Ger-
any) and ACV (Zovirax; Glaxo Wellcome, Hamburg, Ger-
any) were applied subcutaneously at daily doses of 30
g/kg (ACV) or 15 mg/kg (GCV). The dosage was based
n clinical protocols and on previous studies in ma-
aques (Bo¨ttiger and O¨berg, 1996). As soon as severe
symptoms were realized, the animals were killed and
subjected to necropsy.
Analysis of blood and necropsy samples
Leukocytes from Callithrix jacchus blood samples
ere sedimented and treated for 5 min with ACK buffer
0.15 M NH4Cl, 1 mM KHCO3, 0.1 mM EDTA, pH 7.3). The
PBMCs were washed in saline and either stored as
frozen cells for PCR or used for cocultivation with OMK
cells for virus isolation. Moreover, PBMC samples were
taken into culture without interleukin-2 to isolate leuke-
mia cell lines. Lysates of PBMC samples or of leukemiacell lines were subjected to routine PCR using the fol-
lowing sets of primers. The tk gene of HSV-1 was mon-
itored with HF344 59-AAT-GGG-GTC-TCG-GTG-GGG-TAT-
C-39 and HF370 59-ATT-ACG-ACC-AAT-CGC-CC-39. Virus
DNA of wild-type and mutant strains was detected with
the orf75-specific primers HF596 59-TGG-CTG-CTA-ACA-
GGC-ATG-G-39 and HF597 59-AGC-ACG-TTG-CCC-GAG-
ATT-G-39.
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